Iconovo AB (publ) (ICO.ST)
SEK 4.17
(-2.11%)
SEK 4.17
(-2.11%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.39 SEK | 22.85% |
| 2022 | -5.69 SEK | -80.63% |
| 2021 | -3.15 SEK | -43.18% |
| 2020 | -2.20 SEK | -35.8% |
| 2019 | -1.62 SEK | -145.45% |
| 2018 | -0.66 SEK | -344.44% |
| 2017 | 0.27 SEK | -37.21% |
| 2016 | 0.43 SEK | 105.78% |
| 2015 | -7.44 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.70 SEK | -16.67% |
| 2024 Q1 | -0.69 SEK | 17.86% |
| 2024 Q2 | -0.60 SEK | 13.04% |
| 2023 FY | - SEK | 22.85% |
| 2023 Q4 | -0.84 SEK | 13.4% |
| 2023 Q3 | -0.97 SEK | 24.22% |
| 2023 Q2 | -1.28 SEK | 6.57% |
| 2023 Q1 | -1.37 SEK | 35.38% |
| 2022 Q2 | -1.38 SEK | -33.98% |
| 2022 FY | - SEK | -80.63% |
| 2022 Q4 | -2.12 SEK | -85.96% |
| 2022 Q3 | -1.14 SEK | 17.39% |
| 2022 Q1 | -1.03 SEK | 0.96% |
| 2021 FY | - SEK | -43.18% |
| 2021 Q3 | -0.43 SEK | 50.0% |
| 2021 Q2 | -0.86 SEK | 5.49% |
| 2021 Q4 | -1.04 SEK | -141.86% |
| 2021 Q1 | -0.91 SEK | -56.9% |
| 2020 Q4 | -0.58 SEK | -132.0% |
| 2020 Q3 | -0.25 SEK | 69.51% |
| 2020 Q2 | -0.82 SEK | -49.09% |
| 2020 FY | - SEK | -35.8% |
| 2020 Q1 | -0.55 SEK | 50.45% |
| 2019 Q4 | -1.11 SEK | -326.92% |
| 2019 Q3 | -0.26 SEK | 38.1% |
| 2019 Q2 | -0.42 SEK | -700.0% |
| 2019 Q1 | 0.07 SEK | -69.57% |
| 2019 FY | - SEK | -145.45% |
| 2018 Q4 | 0.23 SEK | 174.19% |
| 2018 Q2 | 0.05 SEK | 106.85% |
| 2018 Q1 | -0.73 SEK | -102.24% |
| 2018 FY | - SEK | -344.44% |
| 2018 Q3 | -0.31 SEK | -720.0% |
| 2017 Q4 | 32.65 SEK | 260.6% |
| 2017 Q3 | -20.33 SEK | -10265.0% |
| 2017 Q2 | 0.20 SEK | 176.92% |
| 2017 FY | - SEK | -37.21% |
| 2017 Q1 | -0.26 SEK | 0.0% |
| 2016 FY | - SEK | 105.78% |
| 2015 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acarix AB (publ) | -0.16 SEK | -2643.75% |
| ADDvise Group AB (publ) | 0.56 SEK | 883.929% |
| ADDvise Group AB (publ) | 0.56 SEK | 883.929% |
| Arcoma AB | 0.19 SEK | 2410.526% |
| Bactiguard Holding AB (publ) | -3.95 SEK | -11.139% |
| BICO Group AB (publ) | -12.99 SEK | 66.205% |
| Boule Diagnostics AB (publ) | 0.64 SEK | 785.938% |
| CellaVision AB (publ) | 5.46 SEK | 180.403% |
| Clinical Laserthermia Systems AB (publ) | -23.76 SEK | 81.524% |
| Chordate Medical Holding AB (publ) | -0.13 SEK | -3276.923% |
| C-Rad AB (publ) | 1.05 SEK | 518.095% |
| Duearity AB (publ) | -0.40 SEK | -997.5% |
| Dignitana AB (publ) | -0.25 SEK | -1656.0% |
| Episurf Medical AB (publ) | -0.36 SEK | -1119.444% |
| Getinge AB (publ) | 8.86 SEK | 149.549% |
| Scandinavian Real Heart AB (Publ) | -0.70 SEK | -527.143% |
| Integrum AB (publ) | 0.23 SEK | 2008.696% |
| Luxbright AB (publ) | -0.37 SEK | -1086.486% |
| Mentice AB (publ) | -0.11 SEK | -3890.909% |
| OssDsign AB (publ) | -1.59 SEK | -176.101% |
| Paxman AB (publ) | 0.44 SEK | 1097.727% |
| Promimic AB (publ) | -0.50 SEK | -778.0% |
| Qlife Holding AB (publ) | -526.52 SEK | 99.166% |
| SciBase Holding AB (publ) | -0.51 SEK | -760.784% |
| ScandiDos AB (publ) | -0.32 SEK | -1271.875% |
| Sectra AB (publ) | 2.22 SEK | 297.748% |
| Sedana Medical AB (publ) | -0.60 SEK | -631.667% |
| Senzime AB (publ) | -1.45 SEK | -202.759% |
| SpectraCure AB (publ) | -0.21 SEK | -1990.476% |
| Stille AB | 5.31 SEK | 182.674% |
| Vitrolife AB (publ) | -28.44 SEK | 84.564% |
| Xvivo Perfusion AB (publ) | 3.07 SEK | 242.997% |